Windlas Biotech Limited Buyback (Windlas Biotech Buyback 2022) Detail

The Windlas Biotech Buyback 2022 is a Open Market Through Stock Exchange.

The Windlas Biotech Buyback 2022 is being offered at Rs ₹325 per share per equity share.

There is no ratio applicable in case of open market offer through stock exchange mechanism.

There is no concept of record date in case of open market through stock exchange mechanism.

The Windlas Biotech Buyback 2022 has announced a buyback for an aggregate amount of not more than Rs. ₹25.00 Crores with pricing of Rs.₹325 per share.

The buyback is being undertaken for the following reason:

1.To return surplus funds to the equity shareholders of the Company.

2. To improve return on equity, by reducing in equity base, thereby leading to a long-term increase in the value of shareholders.

Public Announcement

Any equity shareholder holding the shares in Demat form can participate in the buyback offer through their stockbroker. The physical shareholder can participate only once the shares get converted into a Dematerialized form.

The shareholder needs to inform their broker on the details of the Equity shares they wish to sell. The broker will place a sell order whenever the company places a buy order for the buyback. The trade would get executed at the offer price or lesser only when the price offered by the shareholder matches with the buy order placed by the company.

The Windlas Biotech Buyback 2022 offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one's need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.